Please login to the form below

Genesis Research and Clinical Outcomes Solutions announce innovative partnership

International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS).

International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS).

As the regulatory landscape with respect to RWE continues to evolve, this innovative partnership brings together COS’s Clinical Outcomes Assessment scientific and clinical trial expertise and the evidence-based expertise of Genesis Research – keeping both companies firmly at the forefront of this ever-changing landscape to the wider benefit of clients, payers, and regulators.

Established in 2013, COS is a global leader in delivering innovative science to capture and communicate the patient voice, in order to provide actionable evidence in clinical drug development through qualitative and quantitative research, with a specific focus on Clinical Outcomes Assessments.

Genesis Research is an international RWE and HEOR organization that delivers scientifically rigorous, tech-enabled solutions to pharmaceutical, biotech, and medical device clients across the product lifecycle.

Stacie Hudgens, Chief Executive Officer at Clinical Outcomes Solutions, said:

“Clinical Outcomes Solutions was founded in 2013 with a specific focus on bringing innovative scientific solutions to patient-centered research. Our longstanding relationship with Genesis Research transitioning to a scientific partnership with the Oncology Outcomes network of partners continues to expand that focus.

“Evidence generation of patient-centered outcomes begins with prospective and clinical studies and expands through real-world treatment experience and symptoms management. This partnership, along with the additional Oncology Outcomes partners, provides Life Sciences Companies (LSCs) with a comprehensive body of evidence to support new anti-cancer therapy clinical development programs.”

Chris Pashos, Member, Board of Directors, Genesis Research, said:

“Regulatory bodies around the world have made Real-World Evidence and Clinical Outcomes Assessments central to their consideration of new therapies developed by Life Sciences Companies. This partnership offers LSCs the combined capabilities of leaders in these areas. Together the partnership can ensure that LSCs develop and execute timely strategies that will meet the evidentiary requirements of regulators.”

Susan Oliveria, Chief Scientific Officer, Genesis Research, said:

“RWE and COA are now recognized as central to the development and commercialization of new therapies. The partnership offers LSCs the ability to successfully plan and execute an integrated evidence generation plan that will be patient-centric and meet the needs of regulators, payers, medical professionals, and the patient community.”

Tara Symonds, Chief Science Officer at Clinical Outcomes Solutions, said:

“Real-world studies to capture patient-centred effectiveness data require careful design, implementation and analysis given the often-uncontrolled nature of the study design. Bringing together our organizations – and with this our respective skillsets and proven expertise – will provide an industry-leading offering for Life Sciences Companies to leverage, especially given the increasing interest and request for such data by both regulators and payers.”


Further information:

About Clinical Outcomes Solutions

Clinical Outcomes Solutions, founded in 2013, is a solution-focused team with global experience committed to bringing together the right team of experts to approach medical research questions. The expert team provides clients with the most effective clinical outcome solution to help make the right patient care value decisions. COS has expertise in qualitative and quantitative research that will result in actionable evidence to support clinical and regulatory strategies for both the US and European markets. For more information, please visit www.clinoutsolutions.com.

About Genesis Research
Genesis Research is an international Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) research organization that supports the life sciences industry. As a leader in evidence strategy, generation and communication, the company also supports pharmaceutical and biotech clients with tech-enabled, dedicated partnerships delivered via a unique engagement model that enables life sciences companies to address complex needs with unmatched timeliness and quality. For more information, visit www.genesisrg.com.


Contact:

Genesis Research: Richard Chumbley rchumbley@genesisrg.com

Clinical Outcomes Solutions: Clare Grove clare@makeitdrive.co.uk

21st July 2022

Share

Tags

Company Details

Genesis Research

+1 888 503 2680

Contact Website

Address:
111 River Street
Suite 1120
Hoboken
NJ
07030
United States

Latest content on this profile

Leading pharmaceutical executive Jennifer Fillman joins evidence-based solution provider Genesis Research as Chief Financial Officer
International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to joining Genesis Research, Ms. Fillman was Senior Vice President and CFO Clinical Solutions at Syneos Health.
Genesis Research
Genesis Research and Syapse combine forces to offer RWE and data to oncology innovators
Genesis Research is delighted to announce a strategic partnership with Syapse®, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations.
Genesis Research
Genesis Research and Clinical Outcomes Solutions announce innovative partnership
International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS).
Genesis Research
Genesis Research Acquires Market Access Transformation
Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”), a leading provider of technology-enabled payer research platforms.
Genesis Research
ISPOR 2022: a retrospective

Genesis Research
Genesis Research - an introduction

Genesis Research